THE BIOTECH GROWTH TRUST PLC - Transaction in Own Shares
Date: 2012-01-27 12:00:39 | Category: Advertising & Marketing
Following this transaction and in conformity with the provisions of the Transparency Directive, the Company hereby notifies the market that; the total number of Ordinary shares that the Company has in issue, less the total number of Ordinary shares bought back for cancellation by the Company following such purchase, and therefore, the total number of voting rights in the Company is 62,240,426. The Company does not currently hold any Ordinary shares in treasury.
The figure of 62,240,426 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.
For and on behalf of Frostrow Capital LLP Company Secretary For further information, please contact:
Mark Pope Frostrow Capital LLP Tel: 020 3 008 4913
Disclaimer: (c) PRNewswire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions.
Information contained in the releases is furnished by PRNewswire, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Information contained in the releases is furnished by PRNewswire, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
